Question 1

Does CIBC Bancorp USA own IBRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, CIBC Bancorp USA holds 31,435 shares of IBRX (ImmunityBio), worth $275,214.

Question 2

How many shares of IBRX does CIBC Bancorp USA own?

Accepted Answer

As of its Q2 2026 13F, CIBC Bancorp USA holds 31,435 shares of IBRX (ImmunityBio).

Question 3

What is CIBC Bancorp USA's IBRX position worth?

Accepted Answer

As of its Q2 2026 13F, CIBC Bancorp USA's IBRX position is worth $275,214.

Question 4

Is CIBC Bancorp USA buying or selling IBRX?

Accepted Answer

In Q2 2026, CIBC Bancorp USA increased its IBRX position by 6,046 shares (+23.8%).

Question 5

When did CIBC Bancorp USA first buy IBRX?

Accepted Answer

CIBC Bancorp USA already held IBRX in its Q3 2025 13F, the earliest on record, and has listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	31,435	+23.8%	$275,214	0.0%	$8.76	28
2026-Q1	Increased	25,389	+3.5%	$193,960	0.0%	$7.67	24
2025-Q3	First report	24,521	—	$60,322	0.0%	$2.46	0